In the continuation of a years-long pattern, Gallion’s office is again the target of complaints from a local government about unfair practices and exaggerated findings.

Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) Kidney ...

School districts in the DMV and nationwide are increasingly taking steps to keep students safe and the school security ...

Maxus Mining Inc. (“Maxus” or the “Company” ) (CSE: MAXM | FRA: R7V ), is pleased to provide a summary of exploration highlights on the western block of its flagship Alturas Antimony Project (Please ...

The addition of New Gold's two Canadian mines results in a combined company with seven North American operations generating $3 billion of expected EBITDA and $2 billion of expected free cash flow in ...